TACI/TNFRSF13B/CVID Antibody (006), DyLight 350, Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB069072-Each-of-1 | In Stock | ₹ 60,698.00 |
NB069072 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 60,698.00
GST (18%): ₹ 10,925.64
Total Price: ₹ 71,623.64
Antigen
TACI/TNFRSF13B/CVID
Classification
Monoclonal
Conjugate
DyLight 350
Formulation
50mM Sodium Borate
Host Species
Rabbit
Purification Method
Protein A purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Form
Purified
Applications
ELISA
Clone
6
Dilution
ELISA
Gene Alias
CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Human TACI/TNFRSF13B/CVID (O14836-2; Ser2-Thr120).
Quantity
0.1 mL
Research Discipline
Apoptosis, B Cell Development and Differentiation Markers, Signal Transduction
Gene ID (Entrez)
23495
Content And Storage
Store at 4°C in the dark.
Isotype
IgG
Related Products
Description
- TACI/TNFRSF13B/CVID Monoclonal specifically detects TACI/TNFRSF13B/CVID in Human samples
- It is validated for ELISA.